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Abstract 
Des(l-38) factor VII, and des(l--44) factor VII, were obtained by limited proteolysis. The binding of tissue factor to these factor VII,-derivatives 
was assessed from its stimulation of the proteolytic activity on chromogenic oligopeptide substrates. Compared to native factor VII, (Kay = 0.6 + 0.1 
riM), Tissue factor binds to des(l-38) factor VII, with a lower, but still signiticant affinity (Kw = 4.8 + 0.3 nM). The activity of des(I-44) factor 
VII, was only slightly stimulated by TF (KTF -- 200 nlVO. Binding of TF depends critically on the presence of Ca 2+ ions. Ca 2+ ions stimulated the activity 
of factor VII JTF with an apparent K~ = 0.16 + 0.02 raM. Factor VII, in the absence of tissue factor was stimulated by Ca 2+ with an apparent 
K~ = 0.05 + 0.01 raM, and similar K~ values were obtained for the truncated erivatives of factor VIIa. Measurements of Ca2+-induced changes 
in intrinsic protein fluorescence suggest a conformational change. The Ca 2+ ion concentration at which this change occurred was higher for des(I-44) 
factor VII, (apparent Kc~ = 0.14 mM) than for des(I-38)- and native factor VII, (apparent K~ = 0.04 mM). The Tb 3+ ion luminescence t chnique 
was used to further investigate he Ca 2+ binding sites. Tb 3+ ions bound with a lower affinity to des(l-44) factor VII, than to des(1-38)-and native 
factor VIIa. The observed rastic decrease in affinity for tissue factor as a result of truncation of the 'hydrophobic stack' residues 39--44, suggest 
that this region of factor VII~ provides a structural determinant that together with other regions participates in tissue factor binding. 
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1. Introduction 
Factor VII is a vitamin K-dependent glycoprotein 
which participates in the extrinsic pathway of blood co- 
agulation. The primary structure of factor VII [1] is ho- 
mologous to that of other vitamin K-dependent coagula- 
tion proteins uch as factors IX, X and protein C. The 
structure includes a N-terminal T-carboxy-glutamic a id 
(Gla-) containing region, followed by two EGF-like do- 
mains and a C-terminal serine protease part. A well con- 
served 'stack' of hydrophobic residues is situated at the 
interface between the Gla-region and the first EGF-like 
domain. Factor VII is secreted as the one-chain zymogen 
form, and it is activated by limited proteolysis of its 
Arg152-Ile153 peptide bond catalyzed by either factor Xa 
or factor IX~. 
The zymogen factor VII is essentially inactive, and 
even the activated protease, factor VIIi, possesses little 
activity in the absence of the cofactors, Ca 2÷ and tissue 
factor (TF). Thus it is only in the presence of TF and 
CaZ÷-ions that factor VII~ attains appreciable proteolytic 
* Corresponding author. Fax: (45) 31682800. 
Abbreviations: Gla-, 7-carboxy-glutamic acid; EGF domain, epidermal 
growth factor-like domain; TF, tissue factor; (H-D-Ile-Pro-Arg-pNA), 
H-D-isoleyeyl-L-prolyl-L-arginine-p-nitroanilide; tPA, tissue type plas- 
minogen activator; uPA, urokinase-type plasminogen activator; PC, 
phosphatidyl choline; PS, phosphatidyl serine. 
activity towards imple peptide substrates [2] or towards 
its physiological substrates, factors IX and X [3]. 
Ca2+-binding sites has been identified in the Gla-do- 
main, the first EGF domain, and in the protease domain 
[4,5]. Binding of Ca2+-ions to one or more of these sites 
appears to be essential for factor VII interaction with 
TF. The exact mechanism by which Ca2+-ions affect he 
factor VIIa molecule and induce the structure required 
for its interaction with TF is, however, still a matter of 
debate, just as it has been difficult to identify the struc- 
tural determinants of the molecule involved in the inter- 
action with TF. Regions all over the factor VIIa molecule 
have been implicated as possible TF binding sites. The 
fact that the amidolytic activity of factor VIIa is stimu- 
lated by TF and Ca z+ [6] seems to indicate binding of 
these ligands to the catalytic domain, and substantiation 
of this interpretation is obtained by several independent 
observations [5,7-11]. TF interaction with the catalytic 
domain does, however, not exclude additional involve- 
ment of other regions, and the EGF domains of factor 
VIIa have been implicated as possible TF binding sites 
[12-14]. While it has long been known that ?-carboxyla- 
tion of the factor VII Gla-domain is crucial for manifes- 
tation of full biologic activity, it is not until recently that 
the Gla-domain has been directly implicated in TF bind- 
ing. Experiments conducted with Gla-domainless factor 
VIIa suggest that its binding to cell bound TF is mark- 
edly decreased [15]. Also measurements of TF/Ca2+-in - 
duced stimulation of the activity with oligopeptide sub- 
strates uggest that this effect is strongly decreased [16] 
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or absent [17] with Gla-less factor VIIi. Competit ion 
experiments, on the other hand, indicate that separate 
factor VII  Gla-domains (residues 1-38 [6,18] or residues 
1-49 [19]) were incapable of inhibit ing the specific bind- 
ing of factor VI Ia to TF. Apparent ly the Gla-domain 
does not, in itself, contain the structural elements neces- 
sary for the formation of a stable binary factor V I Ia :TF  
'complex. 
To further investigate this interaction we have studied 
two Gla-less derivatives, des(I-38) factor VIIa and 
des(I-43) factor VIIi, in the present work. We confirm 
that truncat ion of the entire Gla-region results in a 
strongly decreased TF  binding, however, the results sug- 
gest that truncat ion of a slightly shorter N-terminal  frag- 
ment, leaving the 'hydrophobic stack' region (residues 
39-43) intact, provides a structure that partly preserves 
the Ca2+-dependent i eraction between TF  and factor 
VIIi. 
2. Materials and methods 
2.1. Proteins 
Recombinant human factor VII, was purified from baby hamster 
kidney cell culture medium as described by Thim et al. [20]. Stock 
solutions containing 0.5-1 mg/ml of protein in buffer: 10 mM glycyl- 
glycine, 50 mM NaC1, 10 mM CaC12, pH 7.4 were stored at -20°C. 
Des(I-38) factor VIIm, kindly provided by Dr. T. Jergensen (Novo 
Nordisk A/S, Denmark), was prepared as described by Sakai et al. [15]. 
Des(I-44) factor VII,, kindly provided by Dr. E.M. Nicolaisen (Novo 
Nordisk A/S, Denmark), was prepared as described [21]. Ca 2+ ion 
depleted factor ViIa preparations were obtained after two desalting 
steps: (i) gel filtration on a PD-10 column equilibrated with 10 mM 
glycylglycine, 0.1 M NaCI pH 6.5, essentially asdescribed by the man- 
ufacturer (Pharmacia AB, Upsala, Sweden), and (ii) by ion-exchange 
using Chelex 100 (Bio-Rad, Richmond, CA). Approximately 20 mg 
clielex 100 was added to 3.5 ml (0.05 mg/ml, 1/aM) of gel-filtrated 
protein solution. Recombinant human tissue factor apoprotein, TF, 
(detergent solubilized) was obtained from Corvas International (San 
Diego, CA). Truncated recombinant human tissue factor TFt_2~s was 
kindly provided by Dr W. Kisiel (Albuquerque, NM) 
2.2. Chemicals 
Substrate S-2288 (H-D-Ile-Pro-Arg-pNA) was from KabiVitrum 
(Stockholm, Sweden). TbC13 • 6H20 (99.9% pure) was from Janssen 
Chimic (Brussels, Belgium) and CaCI2 and all other chemicals were 
analytical grade either from Fluka (Buchs, Switzerland) or Merck 
(Darmstadt, Germany). 
2.3. Protein fluorescence Ca z+ ion titration experiments 
The change in intrinsic protein fluorescence induced by Ca 2+ ion 
binding was measured as described before [4]. Titrations with Ca 2+ ions 
were performed by adding series of small volumes (2-6/al) of aqueous 
CaCI 2 (0, 5 mM or 0.5 M) to 1 ml of enzyme (1/aM) in a semimiero 
cuvette. The fluorescence emmision spectrum (Ex: 280 urn, Era: 310- 
400 urn) was measured after each addition. The Ca 2+ ion concentration 
was in the range 0-1 mM. Fluorescence intensity, F  was taken as the 
area of the peak centred at 337 nm and the relative fluorescence change 
was calculated as (Fo - F)IFo, where F0 was the intensity in the absence 
of Ca 2+ ions. 
2.4. Tb 3+ ion phosphorescence experiments 
Tb 3+ ion phosphorescence experiments were performed as described 
before [4]. Spectra were recorded using a Perkin-Elmer LS-50 spec- 
trofluorometer quipped with FLDM software. Excitation was pro- 
vided by a pulsed Xenon light source with a width at half peak intensity 
of less than 10/as. The background ue to straylight and intrinsic 
protein fluorescence was eliminated by insertion of a 390 nm cut-off 
falter in the emission beam and by measurements of the phosphores- 
cence intensity with a 50/as delay. The protein-Tb 3+ ion complex was 
excited at 285 nm (slit width 15 nm), and phosphorescence int nsity 
(a.u.) was recorded in the range 420-640 nm (slit width 5 nm). 
Titration was performed by adding series of small volumes (2 or 4 
/al) of aqueous TbC13 (5 mM) to 1 ml of enzyme (1/aM), in the absence 
or presence of Ca 2+ ions in a semimicro cuvette. A phosphorescence 
spectrum was measured after each addition. The Tb 3+ ion concentration 
was in the range 0-100/aM. The integrated phosphorescence i t nsity, 
I, was in each case taken as the area under the 544 nm emission peak 
(535-560 urn). 
2.5. Enzyme activity 
Activity measurements were performed in 96 well microtiter plates. 
The absorbance at405 nm, A4o5, was measured on a MCC/340 photom- 
eter from Labsystems (Helsinki, Finland). Control experiments at the 
lowest and the highest Ca 2+ ion concentration revealed a linear increase 
in A405 over 30 rain after addition of enzyme. 
The apparent dissociation constant (Kay) for the binding of TF to 
factor VII, was determined by measuring the amidolytic activity as a 
function of TF concentration ata fixed concentration f factor VII, 
assuming one class of high affinity binding sites, and calculated essen- 
tiaUy as described by Krishnaswamy [22]. Data analysis was performed 
using the nonlinear, least square regression program ENZFITTER 
(Biosoft, Cambridge, UK). 
The apparent constant, Kc,, for the Ca2+-induced stimulation of 
factor VII, amidolytic activity, v, was determined (see e.g. [23]) using 
Equation 1: 
v - v0 _ (c~ "" [Ca2+] 
vo - 1) Kc, + [Ca 2+] (1) 
where v0 is the rate in the absence of Ca 2÷, and ~ is the enhancement 
factor obtained at an infinite xcess of Ca 2+. 
3. Results 
3.1. Enhancement  o f  amidolyt ic activity by TF  
The factor VIIa catalyzed cleavage of the substrate, 
D-I le-Pro-Arg-pNA in the absence of Ca 2÷ and TF  was 
measured. The activity was extremely low, although 
measurable even in the presence of 25 mM EDTA. At 
saturating concentrations Ca 2+ this activity was en- 
hanced by a factor 3-4, and a further 7- to 8-fold en- 
hancement was observed in the presence of an excess of 
TF. 
Several investigators have determined the dissociation 
constant, KTF, for the interaction between factor VIIa 
and TF  by measuring the increase in amidolytic activity 
induced by TF. A similar series of experiments i  shown 
in Fig. 1A. The activity of intact factor FVI I  a was 
strongly enhanced by the addit ion of an approximately 
equivalent molar  amount  of TF. Analysis of the data in 
terms of a tight binding l igand (n = 1) using the approach 
outl ined by Kr isnaswamy [22] leads to a KXF = 0.6 + 0.1 
nM. When the same type of experiment was performed 
with the two des-Gla derivatives of factor VIIa the 
amount  of TF  required for enhancement was much 
higher. TF  bound to des(I-38) factor VIIa with an appar- 
ent KTF = 4.8 + 0.3 nM,  whereas the stimulation by TF  
of the des(I--44) factor VIIa was nearly absent and sug- 
gested an apparent KTF ~ 200 nM (Table 1). Measure- 
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Fig. 1. Effect of TF on the amidolytic activity of factor VIIa derivatives. The activity was measured with 0.5 mM H-D-Ile-Pro-Arg-pNA as the substrate 
for factor VII, (10 nM) at various concentrations of TF as indicated. Curve a, authentic factor VII,; curve b, des(l-38) factor VII,; curve c, des(I-44) 
factor VII,. Panel A shows the results with detergent-solubilized fulMength TF; and panel B the results with truncated TF~_2~s. The activity was 
measured in TBS buffer pH 7.4 with 0.1% BSA and 5 mM CaCI2 at 25"C. 
ments with TF~_els lacking the membrane spanning re- 
gion (Fig. 1 B) showed similar effects but the K~ values 
obtained (Table 1) indicated a generally decreased bind- 
ing of TFI_2~s compared to full-length TF. 
3.2. Effect of Ca e+ and on factor VIIa amidolytic activity 
in the presence of TF 
The amidolytic activity of factor VII. in the presence 
of TF was strongly enhanced by the addition of Ca 2÷ 
(Fig. 2A) with a maximum of approximately 20-fold 
stimulation. Apparently this effect was independent of 
the substrate (D-Ile-Pro-Arg-pNA) concentration ap- 
plied. Analysis of the data shown in Fig. 2 according to 
Equation 1 yields an apparent Kc. value for the Ca 2+- 
enhancement of 0.16 + 0.02 mM. Approximately the 
same value (/(-Ca = 0.13 + 0.02 mM) was obtained for the 
Ca 2+ stimulation of the amidolytic activity of the des(l- 
38) factor VII JTF complex (Fig. 2B). 
3.3 Effect of Ca e+ on factor VII a amidolytic activity in 
the absence of TF 
In the absence of TF only approximately 3-fold maxi- 
mal stimulation of the amidolytic activity of factor VII. 
was obtained (Fig. 3). Using Equation 1 an apparent 
Kd = 0.05 + 0.01 mM was obtained for factor VII.. The 
effect of Ca 2+ on the activity of des(I-38) factor VII. and 
des(I-44) factor VII. in the presence of TF was essen- 
tially as described for intact factor VII. (results not 
shown). 
3.4. Effect of Zn e÷ on factor VII a amidolytic activity 
The activity of factor VII. is strongly inhibited by Zn 2÷ 
ions [24]. Fig. 4 shows such inhibition of factor VII. and 
the factor VIIJTF complex activity in the presence of 
various fixed concentrations of Ca 2÷. Factor VII. was 
more sensitive to Zn 2+ inhibition than was the factor 
VII JTF complex. It is seen that Ca 2÷ ions partially pre- 
vented Zn 2+ inhibition. 
Table 1 
K~ and Kc= values for factor VII, derivatives obtained from activity 
measurements 
K~(nM)  K '~(nM)  /~(mM)  K'c~(mM ) 
TF1_263" TFl_21s* TF1_263 # no T1 ~ 
FVII, 0.6 + 0.1 6.0 + 0.4 0.16 + 0.1 0.05 + 0.01 
Des(I-38) FVII, 4.8 + 0.3 33.2 + 0.4 0.10 + 0.2 0.06 + 0.02 
Des(l-44) FVII. ~200 ~200 - -  0.03 + 0.01 
*Results from Fig. 1; 50 mM Tris-HCl, 100 mM NaCi, 5 mM CaCI2, 
0.1% BSA, pH 7.4, 25°C. 
#Results from Figs. 2 and 3; 50 mM Tris-HC1, 100 mM NaCI, 0.1% 
BSA, pH 7.4, 25°C. 
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Fig. 2. Effect of Ca 2+ ions on the amidolytic activity of factor Via derivatives in complex with TF. The reaction mixture contained: 10 nM factor 
VII=, 16 nM TF and the peptidyl substrate H-D-Ile-Pro-Arg-pNA atconcentrations of 0.4 mM (curve a); 0.3 mM (curve b); 0.2 mM (curve c); and 
0.1 mM (curve d). Other conditions were as described inFig. 1. Panel A shows the results obtained with authentic factor VII=, and panel B sohws 
the results with des(l-38) factor VII=. 
3.5. Fluorescence measurements 
Binding of Ca 2+ to intact factor VII~ induces a consid- 
erable quenching of the intrinsic protein fluorescence. 
The tryptophan residue in position 41 may contribute to 
this effect and the effects of Ca 2+ on the fluorescence 
properties of the two des-Gla factor VII~ forms were 
therefore investigated. Table 2 summarizes the results of 
these studies. Binding of Ca 2+ to intact factor VII~ and 
des(I-38) factor VII~ results in quenching of nearly half 
the intrinsic fluorescence, whereas addition to des(I-44) 
factor VIIa of a saturating excess of Ca 2÷ results in much 
less quenching. The apparent Kca obtained for intact-and 
des(I-38) factor VII~ (0.04 mM and 0.03 raM, respec- 
tively) was similar to the value obtained from the kinetic 
measurements on the amidolytic activity in the absence 
of TF. 
As shown in Table 2 also Zn 2+ resulted in a concentra- 
tion dependent quenching of the intrinsic fluorescence. 
In this case the relative changes were approximally the 
same with des(I--44) factor VII~ and factor VIIi. 
3.6. Tb 3+ phosphorescence measurements 
The terbium ion luminescence technique has often 
been used to investigate Ca 2+ ion binding to proteins. 
Since the effective radius of the Tb 3+ ion is the same as 
that of Ca 2+ the two ions are often interchangeable in the 
protein lattice. Tb 3+ may then serve as a reporter mole- 
cule of the Ca 2+ binding site due to absorbtion of energy 
from tryptophanes in close vicinity to the bound Tb 3+, 
followed by phosphorescence emission that can be ob- 
served at 489, 544, 585 and 621 rim. Tb 3+ ions did bind 
each of the three forms of factor VIIa and produced 
strongly enhanced phosphorescence emission intensities. 
Measurements of the phosphorescence as a function of 
the Tb 3+ concentration was used to calculate the appar- 
ent KTb value. The results are listed in Table 2. As previ- 
ously described [4], Tb 3+ ions binds to intact factor VIIa 
and the des(I-38) form with similar affinities, however, 
the affinity for des(I-44) factor VIIa was significantly 
decreased. 
Table 2 
KTo and Kc~ values for factor VII= derivatives obtained by phosphores- 
cence/fluorescence measurements 
Kc~ (UM) Kz~ ~M'~ K~ (aM) 
FVII a 40 10 9 
Des(l-38) FVIIa 30 n.d. 8 
Des(l-44) FVIIa 142 15 30 
10 mM glycylglycine, 100 mM NaC1, pH 6.5, 25°C. 
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Fig. 3. Effect of Ca 2+ ions on the amidolytic activity of factor VI= derivatives. The reaction mixture contained: 300 nM factor VII,, and the peptidyl 
substrate H-D-Ile-Pro-Arg-pNA at concentrations of 0.4 mM (curve a); 0.3 mM (curve b); 0.2 mM (carve c); and 0.1 mM (curve d). Other condi- 
tions were as described in Fig. 1. Panel A shows the results obtained with authentic factor VII,, and panel B sohws the results with des(I-44) 
factor VII,. 
4. Discussion 
4.1. The 'hydrophobic stack' 
It has been shown that binding of TF to factor VII~ 
in the presence of Ca 2+ induces a pronounced enhance- 
ment of the activity with peptidyl substrates [25], and this 
[5,16,22,26-28] as well as other methods [29,30] have 
been used for the assessment of the dissociation constant, 
KTF. Our results (Table 1) on intact FVII, intreaction 
with detergent solubilized TF (KTF = 0.6 + 0.1 nM) and 
with TFl_21 s (Kaw = 6.0 -+ 0.4 nM) agrees reasonably well 
with previous values [22,27]. Much lower values 
(KvF = 7--27 pM) have, however, been obtained in recent 
studies with TF in (PC/PS) phospholipid vesicles [27,30] 
thus indicating that membrane constituents may contrib- 
ute to stabilization of the complex. 
In agreement with previous results the present study 
also shows that truncation of the N-terminal Gla-do- 
main strongly affects the interaction between factor VII, 
and TF as assessed by the amidolytic activity. Some 
studies showed, however, that truncation of the Gla- 
domain resulted in a complete loss of the TF-dependent 
stimulation of activity [17], whereas others observed that 
some augmentation was still preserved in des-Gla factor 
VII~ [16]. Chymotryptic cleavage [17], and also cleavage 
by cathepsin G [21], result primarily in generation of the 
des(I-44) factor VIIa form, whereas auto-cleavage pri- 
marily results in the formation of the des(I-38) form [ 16]. 
Previous studies did not consider the possiblity of dis- 
tinct functional properties of the two des-Gla forms, 
which may, according to our present findings, at least 
partly explain the controversy. Thus the present study 
confirms that truncation of the Gla-(1-44)reglon results 
in a strongly decreased TF binding, however, it also 
suggest that truncation which leaves the 'hydrophobic 
stack' region (residues 39-43) intact provides astructural 
determinant which partly preserves the Ca2+-dependent 
interaction between TF and factor VII,. The interaction 
between TF and des(I-44) factor VII,, but not des(I-38) 
factor VIIa, has been investigated in a recent study [27]. 
The results suggesed that Gla domain depletion pro- 
duced a 10- to 1000-fold decrease in binding of factor 
VII, to TF, and that the most pronounced effect was 
obtained with lipidated TF. Our present results agree 
with the general conclusion, however, the effect hat we 
observe with TFI_21s is somewhat higher than the 10-fold 
decrease in binding observed by these authors with a 
similar TF preparation. 
4.2. Effect of Ca2+-ions on factor VIIa's ability to bind 
to TF 
The Ca 2+ ion-dependency of the amidolytic activity of 
factor VIIa was significantly affected by TF (Table 2). A 
semiquantative explanation for this effect is possible in 
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terms of a model where the enzymatically active form is 
represented by the factor VIIJTF/Ca 2+ complex, and 
where this complex can dissociate to either an 'inactive' 
Ca2+-free - or an 'inactive' TF-free factor VII~ derivative. 
A simplified model of TF/Ca 2+ stimulated activity and 
the corresponding rate equation (Equation 2) is shown 
below: 
KTF KCa 
E. Ca 2+ + TF ~ E. TF. Ca 2+ ~ E-TF + Ca 2+ 
$ 
S--)P 
k xe[S] p= 
Kca KTF 
1 + [--C~a2+] + [TF----] (2) 
This model, which considers the presence only of the 
three predominant enzyme species, the factor VIIJCa 2+ 
complex, the factor VIIa/TF/Ca 2+ complex and the factor 
VII JTF complex, accounts for the decrease in apparent 
/(Ca (/(Ca') with progressive dissociation of the activator 
(TF). 
Our observation that TF affects Kc~ is at variance with 
recent results reported by Butenas et al. [28] who meas- 
ured a Kc~ of 0.27 mM in the absence as well as the 
presence of TF. Also in contrast to these authors we did 
not observe a significant effect on Kc~ of the substrate 
concentration applied (Figs. 2 and 3). The difference may 
be attributed to the difference in substrate used. 
4.3. Binding of Ca e+, Zn e+ and Tb 3+ to des Gla-factor 
VIIa 
The apparent Kc~ obtained from activity measure- 
ments in the absence of TF was found to be 0.05 mM 
close to the value obtained from fluorescence measure- 
ments [4,31], which was suggested to reflect binding of 
Ca 2+ ions to a site in the EGF-1 domain [4,32]. The 
present work shows that Ca 2+ ion binding also affects the 
intrinsic fluorescence ofdes(I-44) factor VIIa. Since nei- 
ther the EGF-1 nor the EGF-2 domain contain trypto- 
phanes, this suggests that residues in the serine protease 
part work as monitors of Ca2+-ion binding, and that 
Trp 4~ is likely to play a minor role for such Ca2+-induced 
fluorescence hanges in the intact molecule. The results 
seem to suggest that Ca2+-ion binding to the EGF-1 do- 
main induces a conformational change in the protein 
with implications for the catalytic properties of the serine 
protease part. The results also agree with previous ug- 
gestions that Ca 2÷ binding appears to be a prerequisite 
to effective TF binding. 
The stimulatory effect of Ca2+-ions, and the antagonis- 
tic, inhibitory effect of Zn2+-ions on the amidolytic activ- 
ity of factor VIIa appears to be rather unique. We have 
tested a number of other proteases including trypsin, 
chymotrypsin, pancreatic elastase, leukocyte lastase, 
cathepsin G, thrombin, factor X~, factor XII~, factor XIa, 
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Fig. 4. Effect of Zn 2÷ ions on the amidolytic activity of factor VI,. The 
reaction mixture contained: 300 nM factor VII=, and 0.4 mM H-D-Ile- 
Pro-Arg-pNA and CaC12 at concentrations of 0.1 mM (curve a); 0.25 
mM (curve b); 0.5 mM (curve c); 2.0 mM (curve d) and 5.0 mM (curve 
e). The Zn 2+ ion inhibition in the absence of Ca 2+ ions is shown for 
comparison (filled squares). The reaction was performed in 50 mM 
Tris-HC1, 100 mM NaC1 0.01% Tween 80, pH 7.4 at 25°C. 
activated protein C, plasmin, tPA and uPA for similar 
effects, but found only rather weak effects of these ions 
on the activity (results not shown). Histidines are prom- 
inent ligands in Zn2+-ion coordination i  zinc binding 
proteins whereas Ca2+-ion usually coordinates with car- 
boxyl oxygens or main chain carbonyl oxygens, and in 
order to account for the apparent antagonistic character 
of these divalent ions, it is therefore most likely that the 
two binding sites are distinct but possibly affecting the 
same local environment. 
We have previously proposed that the Ca2+-binding 
site monitored by Tb 3+ phosphorescence should be attri- 
buted to the Gly2°9-Gln 221 loop of the protease part [4]. 
In accordance with this proposal we found that the 
des(I-44) factor VIIa still able to bind to Tb 3+ ions. This 
allows us to exclude Trp 41 from being involved in non- 
radiative nergy transfer to Tb 3+. Homology considera- 
tions based on the amino acid sequences of trypsin and 
pancreatic elastase points to Trp 284 as the most likely 
candidate for such an interaction with Tb 3+. As indicated 
by comparative measurements of the two des-Gla forms 
(Table 2) apparently the binding of Ca 2+ monitored by 
intrinsic fluorescence, and also the binding of Tb 3+ mon- 
itored by phosphorescence, d creases upon removal of 
L. C Petersen et al. IFEBS Letters 347 (1994) 73-79 79 
the hydrophobic stack residues 39-44. We have no obvi- 
ous explanation for this phenomenon, however, it is pos- 
sible that residues 39-44 contribute to the stabilization 
of the overall structure of the protein in the presence of 
Ca 2+. 
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